Twists and turns in biomarker exploration

“There’s no standardization for cell-free DNA extraction, preparation, and storage,” says Dr. Martin Fleisher. “That’s a major failing. “That’s a major failing. Everybody has their own little method, which is not good.”

Read the full story »

Dr. Martin Fleisher

Carbapenem resistance:
advice from the frontline

“When there’s a carbapenem-resistant organism,” says Eileen Burd, PhD, “we use the Modified Hodge test to confirm.” Positive organisms are flagged in the computer to alert infection prevention staff and nurses on the floor to take proper precautions.

Read the full story »

Eileen Burd, PhD

Checklists 2015: signposts are clarity, consistency

The broadest changes this year involve quality terminology, says Gerald Hoeltge, MD, checklist commissioner and a member of the Checklists Committee. These revisions are a work in progress, but in this round they led to hundreds of changes in wording to make the use of important terms more precise and more consistent.

Read the full story »

Gerald Hoeltge, MD

Superbugs on scopes: how UCLA lab found the outbreak

Dr. Romney Humphries: “The carbapenemase that was present was an OXA-232,” which had been reported only once before in the U.S. “We really didn’t expect to find this,” she says.

Read the full story »

Hal Weiner

August 2015 Issue

Read, save, and print articles from the current issue


Chronological index

Product Guides

Compare all instruments
and software systems


Chronological index


New pathology lab products and industry news

Magazine Issue Archive

» 2013–2015 article index
» 2000–2012 article index

CAP TODAY Hosted Webinars

» Molecular respiratory testing
» Molecular QC
» All webinars

Product Guides

» Compare products side-by-side
» Download product guide PDFs

Quick Links

» Subscribe or renew CAP TODAY
» Search for jobs/Post open positions

CAP TODAY Recommends

CLSI webinars explore IQCP, AST

Upcoming webinars offered by the Clinical and Laboratory Standards Institute will focus on helping laboratory professionals develop their own individualized quality control plans and provide them with new ways to deal with antimicrobial susceptibility testing challenges.

The CPOE Lab Test: Utilization Opportunity

This editorial is brought to you through Roche’s Lab Leaders initiative.

What’s in store for POC testing

A white paper and webinar offered by Orchard Software outline the factors shaping the point-of-care testing market, the benefits and challenges POC tests offer for labs, and the potential for harnessing data from POC tests for use in analytics.

AMP sees bright future for liquid biopsy

The Association for Molecular Pathology recently published a special article that provides a thorough overview of research to date on the minimally invasive “liquid biopsy” approaches to cancer diagnostics.

Roundtable discussions 2015:
The future of the lab in health care

In a collaborative effort to discuss the future of the laboratory in healthcare, Bob McGonnagle, Publisher of CAP Today, gathered with Orchard Software executives for a series of “round table discussions.”

» More CAP TODAY Recommends